Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The Royal Marsden NHS Foundation Trusts
Unit G3, Harbour Yard, Chelsea Harbour
London
SW10 0XD
UK
Contact person: tenders@chelwest.nhs.uk
E-mail: tenders@chelwest.nhs.uk
NUTS: UKI
Internet address(es)
Main address: www.royalmarsden.nhs.uk
Address of the buyer profile: www.royalmarsden.nhs.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NextSeq 550Dx Instrument
Reference number: DN395489
II.1.2) Main CPV code
33100000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Purchase of NextSeq 550Dx instrument which is an FDA-regulated and CE-marked IVD platform that delivers the power of high-throughput next-generation sequencing (NGS) with the affordability of a benchtop system. With dual boot functionality, the NextSeq 550Dx instrument includes a Diagnostic Mode (Dx Mode) and a Research Mode, which provides the flexibility to perform IVD testing, LDT development, and clinical research on a single platform. For large clinical laboratories, the NextSeq 550Dx instrument offers a validated high-throughput platform and provides access to an ever-expanding pipeline of clinical applications in the fields of oncology, reproductive health, and more.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Lowest offer:
1 800 000.00
GBP/ Highest offer:
2 000 000.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UKI
II.2.4) Description of the procurement
Purchase of Illumina NextSeq 550Dx Sequencing System with installation and training and 12 months warranty including parts and labour.
Purchase of Illumina NextSeq 550Dx Warranty Upgrade: Silver Support Plan. Includes full coverage for parts, labour, and travel; Reagent replacement upon HW failures; 1 PM; Remote Technical Support 18x5; 2 business day on-site response target; control SW and HW updates; on-site applications support; discounts on advanced training; remote monitoring available.
Purchase of Illumina NextSeq 550Dx Silver Support Plan for 4 additional years of extended warranty. Includes full coverage for parts, labour, and travel; Reagent replacement upon HW failures; 1 PM; Remote Technical Support 18x5; 2 business day on-site response target; control SW and HW updates; on-site applications support; discounts on advanced training; remote monitoring available.
II.2.5) Award criteria
Cost criterion: Quality
/ Weighting: 60
Cost criterion: Price
/ Weighting: 40
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
The Centre for Molecular Pathology (CMP) provides clinical grade high throughput sequencing facilities to the Royal Marsden Hospital (RMH), the NHS, and via the Institute of Cancer Research (ICR), to many research organisations. They have recently been awarded the tender to be the NHS England genomic lab hub for diagnostic cancer genomic testing for North/West London. The CMP has 2 Illumina Miseq benchtop systems, one existing Illumina Nextseq500 benchtop system, and an Illumina Novaseq6000 system in the laboratory. The Illumina machines have been a success, and are now heavily used. The existing Illumina Nextseq500 system has exceeded capacity and is 50 % owned by ICR for clinical trial projects including pediatric SMPeads study. The Illumina Novaseq6000 has very high capacity, but the CMP also has the requirement for another intermediate capacity sequencer, the Illumina NextSeq550Dx system, with which small gene panels can be run with a suitable balance of turnaround time and cost. More importantly, the CMP also needs an accredited diagnostic (Dx) instrument which can be used with CE-Marked assay workflows, to allow the participation in international trials, and as we move closer to a period of more stringent regulations in view of IVDR. In H2 2019 Illumina will have the first high throughout comprehensive genomic profiling workflow for NGS that will be IVD compliant, which can only be run on the Illumina NextSeq550Dx system. For diagnostic labs, not having this is going to be problematic. No other current instrument of this type exists with a Dx accreditation.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
19/03/2019
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Illumina Centre
19 Granta Park, Great Abington
Cambridge
UK
NUTS: UKI
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
Lowest offer:
1 800 000.00
GBP
/ Highest offer:
2 000 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
High Court
The Strand
London
WC2 A2LL
UK
VI.5) Date of dispatch of this notice
20/03/2019